Mediphar launches a new dosage of ROVASTIN®

Mediphar Labs. has launched in the Lebanese market, ROVASTIN 10 mg, the superstatin.
ROVASTIN is a lipid-lowering agent that is indicated in the treatment of hypercholesterolemia.

We are proud to introduce the two dosages so that the doctor can now choose the appropriate dosage for each patient.

ROVASTIN ® tablets is now available in below dosages:

ROVASTIN 20 mg, pack of 30 tablets
ROVASTIN 10 mg, pack of 30 tablets

Both dosages are reimbursed by local National Social Security Fund (NSSF).

Back to All News

Metasone

Terafan

Omepral

Preniderm

We care about your questions and concerns. Please call the consumer healthcare service:

+961 4 540056 or by email: chs@medipharlabs.com